Detailed synthetic procedures and analytical/spectral data for target compounds
Chemicals and instrumentation. Primaquine biphosphate (purity 97.5 -102.5 by titration with NaOH, according to manufacturer) and triethylamine (purity ≥ 99.5 % by GC, according to manufacturer) were from Sigma-Aldrich.
Cinnamic acids with minimal 98% purity, according to manufacturer, were all from Acros Organics. All solvents were of analytical grade, and purchased to VWR International. NMR analyses were carried out on a Brucker Avance III 400 MHz spectrometer, and samples were prepared in (CD 3 ) 2 SO with tetramethylsilane (TMS) as an internal reference. Chemical shifts are reported downfield in parts per million (ppm) and multiplicity of proton signals is indicated as s (singlet), d (doublet), dd (double doublet), t (triplet), m (unresolved multiplet). High resolution mass spectra (HRMS) were obtained on an LTQ Orbitrap XL / LTQ Tune Plus 2.5.5 spectrometer, and processed with the 2.1.0 Xcalibur software (Thermo Scientific).
General procedure for the synthesis of the ionic liquids. Primaquine was first obtained as a free base, by addition of triethylamine (0.25 mL) to a suspension of primaquine biphosphate (0.1298 g; 0.285 mol) in dichloromethane (4 mL). The mixture was stirred for 30 minutes in ice and in the dark, after which the organic layer was washed with water (3×10 mL), dried over anhydrous sodium sulfate, and evaporated to dryness under reduced pressure. Free primaquine base was quantitatively obtained as a yellow oil. This procedure was repeated as many times as needed.
Free primaquine was next dissolved in methanol, and titrated with an equimolar amount of the relevant organic acid, upon dropwise addition of a methanolic solution of the acid. The neutralization reaction proceeded in the dark at room temperature for 30 minutes, after which methanol was removed by evaporation at reduced pressure and the target ILs obtained as chromatographically homogeneous yellow-orange viscous liquids. Amounts of starting materials used to produce each one of the ILs synthesized are presented on the table below. 
Cinnamic acid derivatives Primaquine

Assays of in vitro activity against Plasmodium liver stages
Inhibition of liver stage infection by test compounds was assessed by measuring the luminescence intensity of lysates of Huh-7 cells infected with a firefly luciferase-expressing P. berghei line, PbGFP-Luc con , as previously described. 27
Huh-7 cells, a human hepatoma cell line, were cultured in 1640 RPMI medium supplemented with 10% v/v fetal calf serum, 1% v/v non-essential amino acids, 1% v/v penicillin/streptomycin, 1% v/v glutamine and 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulphonic acid (HEPES), pH 7, and maintained at 37 °C with 5% CO 2 . For infection assays, Huh-7 cells (1.2 × 10 4 per well) were seeded in 96-well plates the day before drug treatment and infection. Medium in the cells was replaced by medium containing the appropriate concentration of each compound approximately 1 h prior to infection with sporozoites freshly obtained through disruption of salivary glands of infected female Anopheles stephensi mosquitoes. Sporozoite addition was followed by centrifugation at 1700 g for 5 min. The effect of the compounds on the viability of Huh-7 cells was assessed 46 hours after sporozoite addition by the AlamarBlue assay (Invitrogen, UK), using the manufacturer's protocol. Parasite load was assessed at 48 h of infection by luminescence measurement of cell lysates, following addition of the luciferin substrate.
